Cross-linking (CXL) for Keratoconus Treatment in Atlanta, GA
A popular, cutting-edge procedure for treating keratoconus is performed by the world-class doctors at Woolfson Eye Institute.
It is known as cross-linking (CXL) for keratoconus treatment and you can receive the treatment in Atlanta, GA and our nearby office in Canton, GA.
What is Keratoconus?
Keratoconus, often abbreviated to “KC,” is a non-inflammatory eye condition in which the normally round, dome-shaped cornea is abnormally elastic and progressively thins and stretches causing a cone-like bulge to develop. This results in significant visual impairment.
As the cornea begins to stretch forward, the refractive power of the cornea increases, and the eye becomes more myopic (nearsighted), then as the corneal curvature becomes distorted and uneven, it may produce more of an astigmatism. This is known as Keratoconus.
Keratoconus typically becomes noticeable in one’s 20s or 30s and becomes more severe with time. The severity of the disease can vary from mild to severe with the most severe cases requiring a corneal transplant.
However, the severity of the disease and its progression vary tremendously from one individual to another. In some cases, the disease is barely noticeable, while in others it is so severe that vision is seriously compromised.
Corneal Cross-Linking (CXL) for Keratoconus Treatment
CXL is the only known procedure for keratoconus that can help patients keep from progressing and worsening over time.
In fact, R. Doyle Stulting of Woolfson Eye Institute recently co-authored a peer-reviewed publication (read it here) about CXL . The study “demonstrates that CXL is a safe and effective procedure to stop the progression of KC, providing an excellent visual outcome for the vast majority of eyes” (source).
How does corneal cross-linking work?
CXL adds a bond between the collagen fibers in your eye to help your cornea become more stable. In other words, corneal cross linking makes the corneal tissue stronger in order to stop the eye surface from bulging.
Doctors use a combination of eyedrop medication and ultraviolet (UV) light to also make these tissues stronger.
As previously mentioned, the goal of this FDA-approved keratoconus treatment is to keep the cornea from bulging out. Also, corneal crosslinking has the potential to significantly reduce the need for corneal transplants.
Corneal Crosslinking (CXL)
Contact us today to schedule your consultation to get Cross-linking (CXL) for Keratoconus Treatment in Atlanta, GA
Woolfson Eye Institute is proud to now offer corneal collagen cross-linking for the treatment of ectatic (corneal thinning) disorders. We are one of a handful of offices in the country offering this revolutionary new treatment.